DBV Technologies: DBV Technologies Announces Topline Results of Phase III Clinical Trial in Peanut-Allergic Patients Four to 11 Years of Age

Press/Media

Period	20 Oct 2017

Media coverage

Title	DBV Technologies: DBV Technologies Announces Topline Results of Phase III Clinical Trial in Peanut-Allergic Patients Four to 11 Years of Age
Media name/outlet	FinanzNachrichten.de
Country/Territory	Germany
Date	20/10/17
URL	www.finanznachrichten.de/nachrichten-2017-10/42016331-dbv-technologies-dbv-technologies-announces-topline-results-of-phase-iii-clinical-trial-in-peanut-allergic-patients-four-to-11-years-of-age-399.htm
Persons	Kurt Hirschhorn